1
Registered trials
0
Recruiting
1
Unique sponsors
2
Unique IMPs
0
Commercial trials
Drug classes (ATC)
B
Haematology (ATC B)
1
Mechanism of action (INN-stem analysis)
Antiplatelet / NSAID
1 substance
Factor Xa inhibitor (DOAC)
1 substance
Phase IV:
1
Phase IV
1 trial-
EndedUniversity Of Ottawa Heart Institute AcademicACETYLSALICYLIC ACID; RIVAROXABAN
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| University Of Ottawa Heart Institute | Academic | 1 | Phase IV | 0 |